tagline 2003

December 2003

• Give 'em Hell, Hogan: Pointers and Prerogatives From and for the Unrepentant Problem Patient
• Past as Prologue: Expediency, Cost-Cutting Trump Science in Peg-Intron Clinical Development Plan
• TAG 2003: The Year at a Glance

November 2003

• Lexiva Launch: Glaxo Makes Aggressive Push Into Protease Market With New and Improved Amprenavir
• Scrambling the Code: What a Difference a Nucleotide Makes -- Plus IL-15's Role Is STI Outcomes

October 2003

• The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light
• Medi Gap: Congressional Juggling of Medicare Drug Coverage Leaves Many in the Lurch
• Letter to President Bush

September 2003

• Rx Americas: Antiretroviral Therapy in Latin America: North of the Southern Cone, a Good Plan Is Hard to Find
• ACTing UP for Treatment Access in Latin America
• Second Shoe: Doha Dance Has Health Ministries Scheming to Provide Care -- Without Pissing Off Uncle Sam

July 2003

• Saturation Point: Latest Licensure Breaks Records for Ho-Hum Reception, yet What Exactly Is There to Be Excited About?
• Wheat From Chaff: Take-No-Prisoners Tack on TAG Pipeline Report Snubs Host of Drab Wannabes; Cozies up to Fevered Few

June 2003

• Taz-mania, Bedeviled: Activist Coalition’s Cries Threaten To Scuttle BMS’ Race To Full Approval For Wily Reyataz
• Macaques and Men: Debating the Relevance of Super SIVs—Plus Dendritic Cells Make Their Big Screen Debut
• Immune-Based Therapies Still Languish

May 2003

• Escape From the CTLs: Acute Rx Paradigm Dealt Heavy Blow, While Neutralizing Antibodies Stage a Comeback
• End of an Era: Can a Conference (and an Activist) Outlive Its Utility? A Moment of Unabashed Navel Gazing
• TAG at Ten: The Year 2002

April 2003

• Full Count: Having Sired Twin Failures Hivid and Invirase, Roche Tempts Fate With High Profile T-20 Launch
• Tipping Point: MSF, Oxfam Redefine the Possible, and Y2K Activist Trek to Durban Marks a Watershed
• TAG at Ten: The Year 2001

March 2003

• Under Icebergs' Tip: Tissue T-Cell Analysis Represents Renewed Challenge to "Tap and Drain" Orthodoxy
• Yin and Yang: Yokohama, Vancouver, Twin Pacific Ports, Serve as Polar Opposites for Scientific Advances
• Consensus Statement: AIDSVAX Fails to Protect; VaxGen's Claims of Efficacy in Black and Asian Participants Are Misleading and Premature
• Magic With Numbers: AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close
• TAG at Ten: The Year 2000

January/February 2003

• Pushing the Envelope: Critical Issues From TAG's Forthcoming HCV/HIV Co-Infection Report and Analysis
• Necessary Diversions: The Boston AIDS Conference That Never Was -- And Other Grim Tales
• TAG at Ten: The Year 1999